8-KMaterial AgreementsOther Events

METLIFE INC 8-K Report, Agreement Terminated (May 25, 2007)

Filed May 25, 2007For Securities:METMET-PEMET-PFMET-PA

Summary

This 8-K filing by MetLife, Inc. (MET) on May 25, 2007, announces the termination of a $2 billion Amended and Restated Five-Year Letter of Credit and Reimbursement Agreement (L/C Agreement) that was set to expire in 2010. This agreement, dated April 25, 2005, involved MetLife Reinsurance Company of South Carolina (formerly The Travelers Life and Annuity Reinsurance Company) and a group of financial institutions. The termination is directly linked to the execution of a new, long-term financing transaction. The key event is the establishment of a new financing facility, referred to as the "Facility," with an unaffiliated financial institution. This Facility, effective May 24, 2007, has an initial term of 30 years, with potential for annual extensions. It provides up to $2.5 billion in funding, with an option to increase to $3.5 billion, to establish reinsurance trusts. These trusts will secure the obligations of MetLife Reinsurance Company of South Carolina under various reinsurance agreements with other MetLife insurance subsidiaries. This strategic move enhances MetLife's financial flexibility and long-term funding structure.

Key Highlights

  • 1MetLife terminated a $2 billion Letter of Credit and Reimbursement Agreement (L/C Agreement) on May 24, 2007.
  • 2The terminated L/C Agreement was originally established on April 25, 2005, with a five-year term.
  • 3A new financing transaction, termed the "Facility," has been entered into with an unaffiliated financial institution.
  • 4The new Facility has an initial term of 30 years, significantly extending the duration of MetLife's financing.
  • 5The Facility provides up to $2.5 billion in funding, with a potential to increase to $3.5 billion.
  • 6Funds from the Facility will be used to establish reinsurance trusts to secure obligations of MetLife Reinsurance Company of South Carolina.
  • 7This transaction represents a strategic shift to a long-term funding structure for MetLife's reinsurance operations.

Frequently Asked Questions